Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Consecutive Hemoperfusion and Therapeutic Plasma Exchange in Adult Patients With Septic Shock

NCT06404424 is registered in ClinicalTrials.gov with Efferon JSC as lead sponsor.

NCT NCT06404424
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06404424 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Consecutive Hemoperfusion and Therapeutic Plasma Exchange in Adult Patients With Septic Shock
Lead sponsor
Efferon JSC
Phase
Observational
Overall status
Completed
Start date
May 1, 2022
Completion date
March 1, 2024
Enrollment
82 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sepsis, septic shock